STOCK TITAN

Vogenx (VOGX) Stock Price, News & Analysis

VOGX NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
28 64 sessions, August 12, 2026 to November 10, 2026
Largest daily move
+25.4% close of August 18, 2026
1-month change
+9.7% closing prices, October 9, 2026 to November 10, 2026

Company Description

Vogenx (NASDAQ: VOGX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $286.1M.

VOGX has gained 9.7% over the past month. The last closing price was $19.26.

This page collects what Stock Titan holds for VOGX, including price data, latest news, SEC filings, upcoming events, and short interest trends.

Stock Performance

$19.26
+5.02%
+0.92
Last updated: November 10, 2026 at 16:00
+9.7%
Performance 1 month
$286.1M

Vogenx (VOGX) closed at $19.26 on November 10, 2026. Over the past month, the price has gained 9.7%.

See what a $1,000 investment in VOGX would be worth today

Average down calculator for VOGX

VOGX Metrics & Rankings

Price returns through November 10, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Vogenx has 7 recent news articles, with the latest published 5 days ago. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, clinical trial, management, IPO, offering. View all VOGX news →

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Operating Cash Flow

Upcoming Events

H1
2027
H1 2027 Clinical

Gastroparesis study start

Planned initiation of Vogenx Phase 2 gastroparesis study in H1 2027; enrollment and sites to be announced.
H2
2027
H2 2027 Clinical

EMERGE study results

Topline results from the Phase 2b EMERGE post-bariatric hypoglycemia study expected in H2 2027; timing may vary.

Vogenx has 2 upcoming scheduled events. The next event, "Gastroparesis study start", is expected in H1 2027. Investors can track these dates to stay informed about potential catalysts that may affect the VOGX stock price.

Short Interest History

Last 12 Months

Short interest in Vogenx (VOGX) currently stands at 38.3 thousand shares, up 42.7% from the previous reporting period, representing 0.6% of the float. Since August 2026, short interest has increased by 49.6%.

Days to Cover History

Last 12 Months

Days to cover for Vogenx (VOGX) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

VOGX Company Profile & Sector Positioning

Vogenx (VOGX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing VOGX often look at related companies in the same sector, including Rocket Pharmaceuticals, Inc. (RCKT), Lineage Cell Therapeutics, Inc. (LCTX), Clinuvel Pharmaceuticals Limited (CUVL), CAMP4 Therapeutics Corporation (CAMP), and Bicycle Therapeutics plc (BCYC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VOGX's relative position within its industry.

Frequently Asked Questions

The current stock price of Vogenx (VOGX) is $19.26 as of November 10, 2026.

The market cap of Vogenx (VOGX) is approximately $286.1M. Learn more about what market capitalization means .